Lannett Company Inc (NYSE:LCI)

15.95
Delayed Data
As of Apr 24
 +0.10 / +0.63%
Today’s Change
14.40
Today|||52-Week Range
30.35
-31.25%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$616.9M

Company Description

Lannett Co., Inc. engages in the development, manufacture, market, and distribution of generic pharmaceutical products. The firm also manufactures oral dosage forms including, tablets and capsules. Its pharmaceutical products are distributed to drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations, hospital buying groups, governmental entities and health maintenance organizations. It also provides laboratory services which involve analytical, development, stability, and product identification; product formulation; granulation blending; encapsulation; compression; coating; and packaging. Lannett was founded in 1942 and is headquartered in Philadelphia, PA

Contact Information

Lannett Co., Inc.
9000 State Road
Philadelphia Pennsylvania 19136
P:(215) 333-9000
Investor Relations:

Employees

Shareholders

Other institutional66.76%
Individual stakeholders37.72%
Mutual fund holders36.33%

Top Executives

Timothy C. CrewChief Executive Officer & Director
John AbtVice President, Chief Quality & Operations Officer
Martin P. GalvanCFO, Treasurer & Vice President-Finance
Robert EhlingerChief Information Officer & VP-logistics
Kristin A. ArnoldVice President-Research & Development